AU2016302869B2 - Selected amide of gamma-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse - Google Patents

Selected amide of gamma-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse Download PDF

Info

Publication number
AU2016302869B2
AU2016302869B2 AU2016302869A AU2016302869A AU2016302869B2 AU 2016302869 B2 AU2016302869 B2 AU 2016302869B2 AU 2016302869 A AU2016302869 A AU 2016302869A AU 2016302869 A AU2016302869 A AU 2016302869A AU 2016302869 B2 AU2016302869 B2 AU 2016302869B2
Authority
AU
Australia
Prior art keywords
formula
compound
alcohol
acget61
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2016302869A
Other languages
English (en)
Other versions
AU2016302869A1 (en
Inventor
Roberto Cacciaglia
Antonella Loche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico CT SRL
Original Assignee
Laboratorio Farm C T Srl
Laboratorio Farmaceutico CT SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farm C T Srl, Laboratorio Farmaceutico CT SRL filed Critical Laboratorio Farm C T Srl
Publication of AU2016302869A1 publication Critical patent/AU2016302869A1/en
Application granted granted Critical
Publication of AU2016302869B2 publication Critical patent/AU2016302869B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2016302869A 2015-08-04 2016-08-03 Selected amide of gamma-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse Ceased AU2016302869B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102015000041820 2015-08-04
ITUB2015A002860A ITUB20152860A1 (it) 2015-08-04 2015-08-04 Selezionata amide dell?acido ?-idrossibutirrico e suoi usi nel trattamento dell?abuso da alcool
PCT/EP2016/068517 WO2017021438A1 (en) 2015-08-04 2016-08-03 SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE

Publications (2)

Publication Number Publication Date
AU2016302869A1 AU2016302869A1 (en) 2018-03-15
AU2016302869B2 true AU2016302869B2 (en) 2020-10-22

Family

ID=54542363

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016302869A Ceased AU2016302869B2 (en) 2015-08-04 2016-08-03 Selected amide of gamma-hydroxybutyric acid and uses thereof in the treatment of alcohol misuse

Country Status (24)

Country Link
US (1) US10336687B2 (enExample)
EP (1) EP3331853B1 (enExample)
JP (1) JP6832336B2 (enExample)
KR (1) KR102817897B1 (enExample)
CN (1) CN108026029B (enExample)
AU (1) AU2016302869B2 (enExample)
CA (1) CA2994599C (enExample)
CL (1) CL2018000282A1 (enExample)
CO (1) CO2018002428A2 (enExample)
DK (1) DK3331853T3 (enExample)
EA (1) EA033769B9 (enExample)
ES (1) ES2776628T3 (enExample)
GE (1) GEP20207107B (enExample)
IL (1) IL257314B (enExample)
IT (1) ITUB20152860A1 (enExample)
MX (1) MX2018001239A (enExample)
MY (1) MY185942A (enExample)
PH (1) PH12018550008A1 (enExample)
PL (1) PL3331853T3 (enExample)
PT (1) PT3331853T (enExample)
SM (1) SMT202000337T1 (enExample)
UA (1) UA121994C2 (enExample)
WO (1) WO2017021438A1 (enExample)
ZA (1) ZA201801402B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018310882C1 (en) 2017-07-31 2021-12-09 Novartis Ag Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
KR20200035035A (ko) 2017-07-31 2020-04-01 노파르티스 아게 코카인 사용 감소 또는 코카인 사용 재발 예방에 있어서 마보글루란트의 용도
CN113185403A (zh) * 2021-07-02 2021-07-30 山东国邦药业有限公司 一种甲醚制备环丙胺中间体环丙甲酸甲酯的方法
WO2023126076A1 (en) * 2022-01-03 2023-07-06 Laboratorio Farmaceutico C.T. S.R.L. Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006690A1 (en) * 1996-08-09 1998-02-19 Laboratorio Farmaceutico C.T. S.R.L. USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006690A1 (en) * 1996-08-09 1998-02-19 Laboratorio Farmaceutico C.T. S.R.L. USE OF η-HYDROXYBUTYRIC ACID AMIDES IN THE TREATMENT OF DRUG ADDICTION AND IN PARTICULAR OF ALCOHOLISM

Also Published As

Publication number Publication date
BR112018002245A2 (pt) 2018-09-18
KR102817897B1 (ko) 2025-06-05
JP2018523644A (ja) 2018-08-23
KR20180066033A (ko) 2018-06-18
CA2994599A1 (en) 2017-02-09
GEAP202014717A (en) 2020-01-27
CN108026029A (zh) 2018-05-11
AU2016302869A1 (en) 2018-03-15
ZA201801402B (en) 2019-01-30
CA2994599C (en) 2023-08-29
EA033769B1 (ru) 2019-11-22
US20180230086A1 (en) 2018-08-16
IL257314A (en) 2018-03-29
JP6832336B2 (ja) 2021-02-24
CO2018002428A2 (es) 2018-07-10
US10336687B2 (en) 2019-07-02
PT3331853T (pt) 2020-02-25
CL2018000282A1 (es) 2018-07-13
ES2776628T3 (es) 2020-07-31
EP3331853A1 (en) 2018-06-13
MX2018001239A (es) 2018-07-06
GEP20207107B (en) 2020-05-11
WO2017021438A1 (en) 2017-02-09
MY185942A (en) 2021-06-14
CN108026029B (zh) 2020-12-04
DK3331853T3 (da) 2020-03-16
EP3331853B1 (en) 2019-12-11
ITUB20152860A1 (it) 2017-02-04
SMT202000337T1 (it) 2020-07-08
UA121994C2 (uk) 2020-08-25
IL257314B (en) 2020-04-30
EA033769B9 (ru) 2020-04-10
EA201890419A1 (ru) 2018-07-31
PH12018550008A1 (en) 2018-07-09
PL3331853T3 (pl) 2020-06-15

Similar Documents

Publication Publication Date Title
EP1694318B1 (de) (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum
RU2659784C2 (ru) Сложноэфирное хиральное соединение (n-замещенный имидазол)-карбоновой кислоты, содержащее простую эфирную боковую цепь, его получение и применение
EP3331853B1 (en) Selected amide of -hydroxybutyric acid and uses thereof in the treatment of alcohol misuse
RS61506B1 (sr) Kompozicije fenfluramina i postupci za njihovu pripremu
US6169094B1 (en) Compositions of (S) (-)-amisulpride
US9643971B2 (en) Breathing control modulating compounds, and methods of using same
WO2011133212A1 (en) Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders
KR20150109456A (ko) 프로토파녹사다이올 유도체 및 그의 제조방법과 용도
AU2007325972A1 (en) S-nitrosothiol compounds and related derivatives
JP7599664B2 (ja) 精神障害性疾患を予防および治療するための化合物およびその適用
EP3085698B1 (en) Pain-related compound and medicinal composition
KR20220149582A (ko) 메틸페니데이트-전구약물을 포함하는 조성물, 이를 제조 및 사용하는 방법
BR112018002245B1 (pt) Composto amida selecionado do ácido ?-hidroxybutírico, processo para a preparação do referido composto, uso do referido composto e composição farmacêutica compreendendo o referido composto
JP5792318B2 (ja) ブロムフェナク有機塩、ならびにその製造方法、組成物および使用
JP2018048093A (ja) モルヒナン誘導体及びその医薬用途
JPH07149630A (ja) 血管拡張剤
WO2023126076A1 (en) Medical use of an amide of y-hydroxybutyric acid in the treatment of fragile x syndrome

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired